NDAVAGINALCREAM
Approved
Jan 1947
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 15h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Dienestrol is a vaginal cream containing a nonsteroidal estrogen used for genitourinary symptoms associated with menopause, including vaginal atrophy and dryness. Applied topically to the vagina, it provides localized hormonal therapy with minimal systemic absorption. The drug has been in use since 1947 and remains part of the menopausal symptom management arsenal.
LOE Approaching
This legacy product faces imminent loss of exclusivity with moderate competitive pressure (30), suggesting a contracting commercial organization and transition toward lifecycle management rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on dienestrol offers limited career growth opportunity due to its LOE-approaching lifecycle and zero linked job openings. Roles are primarily defensive commercial positions focused on revenue protection and market share management rather than innovation or launch dynamics.
Brand ManagerField Sales
Worked on DIENESTROL at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.